HIPAA Privacy Rule Release of Information: Authorization, Consent, and Risk Examples

The HIPAA Privacy Rule governs how covered entities and their business associates handle Individually Identifiable Health Information (PHI). This guide explains when a HIPAA authorization is required, how it differs from consent, what an authorization must include, and practical risk and scenario examples to support Privacy Rule Compliance.

By understanding PHI Use and Disclosure rules and Covered Entity Obligations, you can release information lawfully, reduce breach risk, and respect patient choice across care, operations, and research.

Authorization Requirements

Under the Privacy Rule, a covered entity may use or disclose PHI only as permitted by HIPAA or as authorized in writing by the individual. Authorization is generally required for uses and disclosures outside treatment, payment, and health care operations (TPO) and outside specific permitted or required categories.

Authorization is not required for: TPO; disclosures to the individual; uses required by law; certain public health and health oversight activities; specific law enforcement and judicial purposes; limited decedent, organ donation, and workers’ compensation contexts; and when PHI is de-identified. A limited data set may be shared under a data use agreement without authorization.

Authorization is required for: most marketing; sale of PHI; disclosures of psychotherapy notes (with narrow exceptions); and many third-party requests unrelated to TPO. Minimum necessary applies to most non-TPO disclosures, and Covered Entity Obligations include documenting decisions, honoring restrictions when applicable, and maintaining records of disclosures.

Consent vs Authorization

Consent is a general, often optional permission a provider may seek to use and disclose PHI for TPO. HIPAA does not mandate consent for TPO, though organizations or state laws may require it. Consent is typically shorter, less specific, and not sufficient for non-TPO sharing.

Authorization is a detailed, written permission for specified PHI uses or disclosures beyond TPO or beyond other permitted categories. It must identify what information will be shared, with whom, for what purpose, and for how long, and it must inform the individual of key rights, including Authorization Revocation.

Authorization Form Elements

A valid HIPAA authorization must be written in plain language and include all core elements and required statements. Ensure your form covers:

• Description of PHI to be used/disclosed (be specific—dates, types, or records).
• Who is authorized to make the disclosure (the covered entity or source).
• To whom the disclosure may be made (person, organization, or role).
• Purpose of the use/disclosure (e.g., legal matter, insurance underwriting, personal request).
• Expiration date or event (e.g., “end of litigation” or a specific date).
• Individual’s signature and date; if a personal representative signs, include authority to act.
• Right to revoke authorization in writing and how to exercise it, noting limits if the entity has already relied on it.
• Whether treatment, payment, enrollment, or eligibility is conditioned on signing (usually not; state exceptions clearly).
• Notice that disclosed PHI might be re-disclosed by the recipient and no longer protected by HIPAA.
• For marketing, sale of PHI, or Research Authorization, include required, activity-specific statements and disclosures.

Research and Authorization

Research Authorization allows use and disclosure of PHI for a specified study or for future research within a described scope. Expiration may be “end of research” or similar event. Compound authorizations may be used in research if regulatory conditions are met and participation choices are clear.

Alternatives exist: an Institutional Review Board (IRB) or Privacy Board may waive or alter authorization when criteria are satisfied; de-identified data is not PHI; a limited data set may be shared under a data use agreement; “preparatory to research” reviews and decedent research may be permitted with required representations to the covered entity.

Always align protocols, participant notices, and data flows to the minimum necessary standard and document determinations to support Privacy Rule Compliance.

Risks of Unauthorized Disclosure

Unauthorized PHI disclosures can cause direct harm to individuals and significant exposure for organizations. Common individual risks include identity theft, financial fraud, stigma or discrimination, employment or insurance consequences, reputational damage, and threats to personal safety.

Organizational risks include breach notification costs, operational disruption, loss of trust, contractual liability, and Enforcement Actions by regulators, which may involve civil monetary penalties and corrective action plans. Strong access controls, verification, and auditing reduce these risks.

Revocation of Authorization

Individuals may revoke their authorization at any time by submitting a written request to the covered entity’s designated contact (often the Privacy Officer). You must honor the revocation, except to the extent you have already relied on the authorization to act.

To facilitate Authorization Revocation, provide clear instructions on where to send the request, how it will be processed, and when it takes effect. Explain that revocation cannot undo disclosures already made and may affect ongoing activities that depended on the authorization.

Examples of Required Authorization

• Marketing that is not face-to-face and involves financial remuneration from a third party to the covered entity.
• Sale of PHI in exchange for remuneration, except for narrow regulatory exceptions.
• Disclosure of psychotherapy notes for most purposes, including to third parties or for marketing, absent a specific authorization for those notes.
• Releasing PHI to an employer for employment decisions or fitness-for-duty evaluations unrelated to TPO.
• Providing records to a life or disability insurer for underwriting or policy decisions at the insurer’s request.
• Sending full medical records to an attorney or other third party not involved in TPO when the patient is not the requestor.
• Sharing PHI with media or posting on websites or social media, including images or case details that could identify a patient.
• Disclosing PHI to a school, camp, or sports organization beyond limited immunization confirmations permitted by law.
• Providing PHI to an app developer or analytics firm for product development or marketing when not at the individual’s direct request.
• Research disclosures when there is no IRB/Privacy Board waiver and data is not de-identified or in a limited data set under a data use agreement.

In practice, verify the purpose, confirm whether another HIPAA permission applies, and use authorization when a disclosure falls outside those permissions. This approach supports Privacy Rule Compliance, protects patients, and reduces organizational risk.

FAQs

What is the difference between consent and authorization under HIPAA?

Consent is a general permission some organizations use to allow PHI Use and Disclosure for treatment, payment, and health care operations. Authorization is a detailed, written permission required for uses or disclosures beyond those routine purposes or other permitted categories, and it must include specific elements and required statements.

What are the core elements required in a HIPAA authorization form?

Core elements include a description of the PHI, who may disclose it, the recipient, the purpose, an expiration date or event, the individual’s signature and date (or representative’s authority), and required statements about Authorization Revocation, any conditioning of services, and the potential for re-disclosure.

How can individuals revoke their HIPAA authorization?

Individuals revoke by submitting a written request to the covered entity’s designated contact. The revocation takes effect once processed but does not undo actions already taken in reliance on the authorization. Covered Entity Obligations include clear instructions and timely processing of revocation requests.

What are the risks of unauthorized disclosure of PHI?

Risks include identity theft, financial loss, stigma or discrimination, reputational harm, and threats to personal safety. Organizations face breach response costs and potential Enforcement Actions. Robust verification, minimum necessary practices, and auditing help prevent unauthorized disclosures.